Related Experiment Video
Updated: Mar 9, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Outcomes and Sex Differences in Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy-Insights from a
Tetsuo Yamaguchi1, Mitsuyoshi Takahara2, Shun Kohsaka3
1Department of Cardiovascular Center, Toranomon Hospital, Tokyo, Japan.
Insights
Alcohol septal ablation (ASA) effectively reduces left ventricular outflow tract gradients in obstructive hypertrophic cardiomyopathy (HOCM) patients in Japan. While safe, female sex is linked to higher risks of heart block requiring pacemakers.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Imaging
Background:
- Obstructive hypertrophic cardiomyopathy (HOCM) significantly impacts patient quality of life.
- Alcohol septal ablation (ASA) is an established treatment for symptomatic HOCM.
- Limited data exist on current ASA practices and outcomes specifically within Japan.
Purpose of the Study:
- To evaluate the current practice and in-hospital outcomes of ASA in Japan.
- To identify predictors of procedural success and complications following ASA.
- To assess the safety and efficacy of ASA for HOCM patients in a Japanese nationwide registry.
Main Methods:
- Analysis of data from 634 patients who underwent ASA between January 2019 and December 2022.
- Data extracted from the nationwide prospective J-SHD registry.
- Multivariate logistic regression used to identify predictors of success and complications.
Main Results:
- Successful alcohol injection in 99.6% of cases, significantly reducing LVOT gradient (72.0 to 20.9 mmHg).
- Low in-hospital mortality (0.16%) and low rates of ventricular arrhythmia (0.63%).
- High-grade heart block requiring permanent pacemaker implantation occurred in 7.9% of patients; female sex predicted this complication.
Conclusions:
- Alcohol septal ablation is a safe and effective therapy for symptomatic obstructive hypertrophic cardiomyopathy in Japan.
- Higher pre-procedural LVOT gradient predicts successful gradient reduction.
- Female sex is an independent predictor of high-grade heart block requiring pacemaker implantation.
Abstract:
Recent advances in pre-procedural imaging have improved risk assessment and procedural planning for alcohol septal ablation (ASA) in patients with symptomatic obstructive hypertrophic cardiomyopathy (HOCM). However, limited data exist regarding the current practice and outcomes of ASA in Japan. Data from 634 patients who underwent ASA at 72 hospitals between January 2019 and December 2022 were extracted from the nationwide prospective J-SHD registry. Baseline characteristics, procedural details, and in-hospital outcomes were evaluated, and multivariate logistic regression analyses were performed to identify predictors of procedural success and complications. The cohort consisted predominantly of females (76.5%). The mean procedure time was 168 ± 52 minutes, and the mean alcohol volume injected was 3.0 ± 1.8 mL. Successful alcohol injection was achieved in 99.6% of cases, resulting in a significant reduction of the left ventricular outflow tract (LVOT) gradient from 72.0 ± 44.0 to 20.9 ± 24.6 mmHg (p <0.001). In-hospital mortality was 0.16%, while ventricular arrhythmia and high-grade heart block requiring permanent pacemaker implantation occurred in 0.63% and 7.9% of patients, respectively. A higher pre-procedural LVOT gradient predicted successful gradient reduction, whereas female sex independently predicted high-grade heart block. In conclusion, this nationwide registry demonstrated that ASA is a safe and effective therapy for HOCM in Japan. Female sex may represent a potential risk factor for conduction disturbances requiring pacemaker implantation.
More Related Videos
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
10:39Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies